BackSenti Biosciences Overview

Senti Biosciences Long Term Debt

Track Senti Biosciences's long-term debt ($13M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$12.74M
75.81% YoYΔ $-39.92M vs prior year quarter

Peer trimmed avg / median

Loading

Senti Biosciences Long Term Debt History

Loading

Senti Biosciences vs. peers: Long Term Debt Comparison

Loading

Senti Biosciences Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Senti Biosciences (SNTI) FAQ

As of the most recent data (June 2026), SNTI shows a long-term debt of $13M. That compares with $53M in the prior-year period — down 75.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SNTI's long-term debt is now $13M (was $53M) — a 75.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Senti Biosciences is outperforming or lagging.

Tracking SNTI's long-term debt over time shows whether Senti Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $53M in the prior-year period — down 75.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Senti Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $13M) with ownership activity and broader fundamentals.